Following the mid-stage readout, Verastem Oncology has decided to move away from its investigational pancreatic cancer drug ...
Purdue researchers developed a mass spectrometry platform that accelerates cancer drug discovery by integrating synthesis, ...
First closing of $27 million Series A financing - - Fundingwill support Phase 1b/2a clinical trial of MVB-101, a prostate-specific membrane antigen x folate receptor alpha (PSMA ...
Researchers at the Purdue Institute for Cancer Research (PICR) have developed a next-generation technology platform designed to dramatically accelerate one of the slowest and most challenging stages ...
Georgia’s only National Cancer Institute (NCI)-designated Comprehensive Cancer Center; well recognized at the forefront of cancer innovation and discovery nationwide ...
Daraxonrasib doubles survival — a RAS‑targeting drug development breakthrough.
A spate of new research suggests that GLP-1 drugs like Ozempic and Wegovy can protect you against cancers like in the lung ...
In a rare move, nonprofit organization Blood Cancer United is buying the remaining supplies of a discontinued investigational ...
Cancer drug development has never moved faster. Yet, for too many patients, the next treatment decision still begins with ...
A pioneering cancer vaccine, developed through a collaboration between the University of Oxford and pharmaceutical giant ...
Cancer research in cats has never received the same attention as research in people or dogs, despite the fact that cats share ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results